Voloridge Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-997,427
Closed -$6.98M 1280
2025
Q4
$6.98M Buy
997,427
+299,086
+43% +$2.34M 0.02% 678
2025
Q3
$5.4M Sell
698,341
-971,979
-58% -$7.59M 0.02% 722
2025
Q2
$14.5M Sell
1,670,320
-806,497
-33% -$5.85M 0.05% 426
2025
Q1
$19.7M Buy
2,476,817
+716,283
+41% +$7.25M 0.07% 367
2024
Q4
$16M Sell
1,760,534
-675,053
-28% -$6.52M 0.06% 416
2024
Q3
$22.4M Buy
2,435,587
+588,588
+32% +$4.87M 0.08% 341
2024
Q2
$18.1M Buy
1,846,999
+939,152
+103% +$11.5M 0.07% 398
2024
Q1
$13.7M Buy
+907,847
New +$16.5M 0.05% 416
2023
Q3
Sell
-1,127,153
Closed -$28.5M 1598
2023
Q2
$28.5M Sell
1,127,153
-819,887
-42% -$20.6M 0.13% 211
2023
Q1
$50.4M Sell
1,947,040
-210,174
-10% -$5.62M 0.25% 108
2022
Q4
$51M Sell
2,157,214
-564,178
-21% -$15.2M 0.28% 78
2022
Q3
$69M Buy
2,721,392
+125,596
+5% +$4.41M 0.37% 46
2022
Q2
$86.2M Buy
2,595,796
+2,299,773
+777% +$97.7M 0.45% 36
2022
Q1
$21.4M Sell
296,023
-135,058
-31% -$9.73M 0.12% 238
2021
Q4
$39.6M Buy
431,081
+392,812
+1,026% +$46.9M 0.22% 116
2021
Q3
$4.85M Buy
+38,269
New +$5.57M 0.03% 693
2020
Q2
Sell
-89,161
Closed -$13.8M 1490
2020
Q1
$13.8M Buy
89,161
+29,132
+49% +$3.39M 0.4% 47
2019
Q4
$5.03M Buy
+60,029
New +$4.57M 0.1% 264
2019
Q1
Sell
-120,067
Closed -$5.95M 1056
2018
Q4
$5.95M Buy
+120,067
New +$7.35M 0.27% 99
2018
Q3
Sell
-88,244
Closed -$5.12M 456
2018
Q2
$5.12M Buy
+88,244
New +$4.31M 0.14% 162
2018
Q1
Sell
-8,318
Closed -$290K 653
2017
Q4
$290K Buy
+8,318
New +$276K 0.01% 448
2017
Q3
Sell
-73,429
Closed -$2.55M 525
2017
Q2
$2.55M Buy
+73,429
New +$2.14M 0.06% 250

Other funds holding TDOC

Voloridge Investment Management's TDOC Position: Q1 2026 in Review

Voloridge Investment Management sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 997,427 shares — an estimated $6.98M sold.

Voloridge Investment Management first reported a position in TDOC in Q2 2017 and held it in 22 quarters. The position peaked at $86.2M in Q2 2022. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Voloridge Investment Management reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 997,427 Teladoc Health shares in Q1 2026, an estimated $6.98M.
  • Voloridge Investment Management first reported a position in Teladoc Health in Q2 2017 and held it in 22 quarters.
  • Voloridge Investment Management's Teladoc Health position peaked at $86.2M in Q2 2022.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.